Ana Carolina Pereira de Godoy, Reinaldo Bulgarelli Bestetti
{"title":"巴西儿童和青少年因COVID-19而住院和死亡率:回顾性研究","authors":"Ana Carolina Pereira de Godoy, Reinaldo Bulgarelli Bestetti","doi":"10.2196/67546","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>COVID-19 is currently one of the most important medical challenges as it affects the entire population, with children and adolescents being infected as easily as adults.</p><p><strong>Objective: </strong>The objective of this study was to evaluate the prevalence of mortality in children and adolescents aged <19 years, compared to that of adults.</p><p><strong>Methods: </strong>This retrospective, observational study analyzed the medical records of all patients diagnosed with COVID-19 by real-time reverse transcription-quantitative polymerase chain reaction who were hospitalized at Hospital de Base and the Infant and Maternal Hospital of São José do Rio Preto, São Paulo, Brazil. Out of a total of 8986 hospitalized patients who were COVID-19 positive, 383 (4.26%) were children and adolescents aged <19 years (group 1), and 8603 (95.74%) were adults (group 2).</p><p><strong>Results: </strong>Overall, mortality was significantly higher (P<.001) in group 2 (2185/8603, 25.4%) compared to group 1 (12/383, 3.1%). A total of 11 (92%) of the 12 patients in group 1 that died had associated diseases. The mortality rates by age group were as follows: infants aged <1 year, 1.6% (2/123); children aged 1-4 years, 4% (4/95); children aged 5-9 years, 2% (1/47); adolescents aged 10-14 years, 2% (1/40); and adolescents aged 15-19 years, 5% (4/78).</p><p><strong>Conclusions: </strong>Mortality from COVID-19 in children and adolescents was significantly lower than that in adults and was associated with other comorbidities.</p>","PeriodicalId":36223,"journal":{"name":"JMIR Pediatrics and Parenting","volume":"8 ","pages":"e67546"},"PeriodicalIF":2.1000,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hospitalization and Mortality in Brazilian Children and Adolescents Due to COVID-19: Retrospective Study.\",\"authors\":\"Ana Carolina Pereira de Godoy, Reinaldo Bulgarelli Bestetti\",\"doi\":\"10.2196/67546\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>COVID-19 is currently one of the most important medical challenges as it affects the entire population, with children and adolescents being infected as easily as adults.</p><p><strong>Objective: </strong>The objective of this study was to evaluate the prevalence of mortality in children and adolescents aged <19 years, compared to that of adults.</p><p><strong>Methods: </strong>This retrospective, observational study analyzed the medical records of all patients diagnosed with COVID-19 by real-time reverse transcription-quantitative polymerase chain reaction who were hospitalized at Hospital de Base and the Infant and Maternal Hospital of São José do Rio Preto, São Paulo, Brazil. Out of a total of 8986 hospitalized patients who were COVID-19 positive, 383 (4.26%) were children and adolescents aged <19 years (group 1), and 8603 (95.74%) were adults (group 2).</p><p><strong>Results: </strong>Overall, mortality was significantly higher (P<.001) in group 2 (2185/8603, 25.4%) compared to group 1 (12/383, 3.1%). A total of 11 (92%) of the 12 patients in group 1 that died had associated diseases. The mortality rates by age group were as follows: infants aged <1 year, 1.6% (2/123); children aged 1-4 years, 4% (4/95); children aged 5-9 years, 2% (1/47); adolescents aged 10-14 years, 2% (1/40); and adolescents aged 15-19 years, 5% (4/78).</p><p><strong>Conclusions: </strong>Mortality from COVID-19 in children and adolescents was significantly lower than that in adults and was associated with other comorbidities.</p>\",\"PeriodicalId\":36223,\"journal\":{\"name\":\"JMIR Pediatrics and Parenting\",\"volume\":\"8 \",\"pages\":\"e67546\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-05-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JMIR Pediatrics and Parenting\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2196/67546\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JMIR Pediatrics and Parenting","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2196/67546","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
摘要
背景:COVID-19目前是最重要的医疗挑战之一,因为它影响到整个人口,儿童和青少年与成年人一样容易受到感染。目的:本研究的目的是评估儿童和青少年的死亡率。方法:本回顾性观察性研究分析了所有在巴西圣保罗 o joss do里约热内卢Preto的de Base医院和母婴医院住院的通过实时逆转录-定量聚合酶链反应诊断为COVID-19的患者的病历。在8986例COVID-19阳性住院患者中,383例(4.26%)为儿童和青少年。结果:总体而言,儿童和青少年的死亡率显著高于成人(p结论:儿童和青少年的COVID-19死亡率显著低于成人,并与其他合并症相关。
Hospitalization and Mortality in Brazilian Children and Adolescents Due to COVID-19: Retrospective Study.
Background: COVID-19 is currently one of the most important medical challenges as it affects the entire population, with children and adolescents being infected as easily as adults.
Objective: The objective of this study was to evaluate the prevalence of mortality in children and adolescents aged <19 years, compared to that of adults.
Methods: This retrospective, observational study analyzed the medical records of all patients diagnosed with COVID-19 by real-time reverse transcription-quantitative polymerase chain reaction who were hospitalized at Hospital de Base and the Infant and Maternal Hospital of São José do Rio Preto, São Paulo, Brazil. Out of a total of 8986 hospitalized patients who were COVID-19 positive, 383 (4.26%) were children and adolescents aged <19 years (group 1), and 8603 (95.74%) were adults (group 2).
Results: Overall, mortality was significantly higher (P<.001) in group 2 (2185/8603, 25.4%) compared to group 1 (12/383, 3.1%). A total of 11 (92%) of the 12 patients in group 1 that died had associated diseases. The mortality rates by age group were as follows: infants aged <1 year, 1.6% (2/123); children aged 1-4 years, 4% (4/95); children aged 5-9 years, 2% (1/47); adolescents aged 10-14 years, 2% (1/40); and adolescents aged 15-19 years, 5% (4/78).
Conclusions: Mortality from COVID-19 in children and adolescents was significantly lower than that in adults and was associated with other comorbidities.